{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/psoriasis/prescribing-information/coal-tar-products/","result":{"pageContext":{"chapter":{"id":"325d4c77-192a-5152-971f-a5f4f1d64fc7","slug":"coal-tar-products","fullItemName":"Coal tar products","depth":2,"htmlHeader":"<!-- begin field 0472c07f-d01a-4220-b9de-b272a87e65c4 --><h2>Coal tar products</h2><!-- end field 0472c07f-d01a-4220-b9de-b272a87e65c4 -->","summary":"","htmlStringContent":"<!-- begin item d0ca4e18-4035-4639-b4d9-c6d3d181cb8c --><!-- end item d0ca4e18-4035-4639-b4d9-c6d3d181cb8c -->","topic":{"id":"a3ecec3a-acde-5ece-90b0-dedc6c08db8b","topicId":"c8702cb0-6f30-44e4-832b-ab9161ee384a","topicName":"Psoriasis","slug":"psoriasis","lastRevised":"Last revised in December 2020","chapters":[{"id":"d0c39045-d8df-5a7e-bd7d-96fef3aefc3a","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"6e22adaa-de33-5d1c-bc1f-9740d238c5a2","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"a7c9da10-9760-5143-bf20-167f1e832103","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"409aaeee-7f7b-53cc-afdc-9ea9034984d6","slug":"changes","fullItemName":"Changes"},{"id":"1677a6dc-645a-58fe-8ed8-8bdfcface768","slug":"update","fullItemName":"Update"}]},{"id":"ca38cddf-4680-5dc4-a0df-79ab9910a789","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"fc350387-9e56-5f4b-b454-3cfa5ecd9a2a","slug":"goals","fullItemName":"Goals"},{"id":"00a9f2b3-e7b5-5394-9762-48d34a0dc722","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"400cbb71-cb76-5ee3-824a-738bc6249b3b","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"ad046045-038c-5b75-8f42-50343d5b824e","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"773d3740-99b6-5a32-b555-968b2efb0b8b","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"0692cf2f-4b3d-5098-afe3-ac07b3c763ff","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"d16fcd88-1021-5238-86e4-2452eee7fdde","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"ef476810-392e-5b83-b527-fe921221cc0b","slug":"definition","fullItemName":"Definition"},{"id":"fb1e0af3-fd46-562a-83d6-33a31640b639","slug":"prevalence","fullItemName":"Prevalence"},{"id":"d6b8dab4-762f-5e9e-a83e-35a3652483b3","slug":"trigger-factors","fullItemName":"Trigger factors"},{"id":"70837c8d-73ae-5bc4-a042-949d31503ca3","slug":"associated-conditions","fullItemName":"Associated conditions"},{"id":"e90f3736-0e28-53fa-8295-309df8aa8e00","slug":"complications","fullItemName":"Complications"},{"id":"9523ad16-6e73-50ba-94bd-64c548f5c313","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"4d0deda5-f89f-59e7-8978-1c3337afdcfe","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"067d150c-d6d4-5992-9319-f86bfeecca88","slug":"assessment","fullItemName":"Assessment"},{"id":"58b4da96-dda6-596b-9570-fd5070898cfe","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"27af05e5-54bf-5bc5-ba76-d1b8f18e7252","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"eaab9e94-c74e-5c84-ba14-d8db3a6dd1e8","fullItemName":"Management","slug":"management","subChapters":[{"id":"82ee7501-0589-54c2-8df7-5a9256a3f1d0","slug":"pustular-or-erythrodermic-psoriasis","fullItemName":"Scenario: Pustular or erythrodermic psoriasis"},{"id":"e4183760-c129-567e-9211-cef27ef68100","slug":"trunk-limbs","fullItemName":"Scenario: Trunk and limbs"},{"id":"6a7e9d56-0d17-5c90-b835-822367fbcd3e","slug":"scalp-psoriasis","fullItemName":"Scenario: Scalp psoriasis"},{"id":"9c7cebad-a77f-5fa8-811a-50815577a51c","slug":"facial-flexural/genital-psoriasis","fullItemName":"Scenario: Facial/flexural/genital psoriasis"},{"id":"6fbadcef-730e-5874-97ad-53e1f12bd5e3","slug":"guttate-psoriasis","fullItemName":"Scenario: Guttate psoriasis"},{"id":"a069495e-d2fe-5fca-9799-1b5f4f874033","slug":"nail-psoriasis","fullItemName":"Scenario: Nail psoriasis"},{"id":"08dc9427-b5ec-59f4-b47b-72a666beacef","slug":"covid-19","fullItemName":"Scenario: COVID-19"}]},{"id":"ce3be64b-a968-59e2-b206-5a055de98330","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"520d3bb6-49cf-5f46-b761-9df1c712ad28","slug":"emollients","fullItemName":"Emollients"},{"id":"2a68bcd1-b92f-579a-955e-f4638d00073f","slug":"vitamin-d-preparations","fullItemName":"Vitamin D preparations"},{"id":"39f1a594-6e44-59b9-bb85-a277475d7386","slug":"salicylic-acid","fullItemName":"Salicylic acid"},{"id":"325d4c77-192a-5152-971f-a5f4f1d64fc7","slug":"coal-tar-products","fullItemName":"Coal tar products"},{"id":"302b90f5-e0d6-53cc-88ce-6a06def02b51","slug":"dithranol-short-contact","fullItemName":"Dithranol (short-contact)"}]},{"id":"00678b76-cc05-5d69-a6be-8760727fb9cf","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"91ae130b-06c7-538c-a295-af4bf7a3dbf1","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"358d84df-224b-5d6b-96cd-c52dfe00a200","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"383c93f2-ae1f-5c75-af43-3a9a448c1669","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"3703e9fb-0103-5fe6-a0ed-192226578ed6","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"d248a57f-2b73-5c2f-89c5-18ed618c3535","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"e35fcef8-37a3-5afe-9250-f527d2c6e017","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"7314bc52-4cb9-530c-a905-917edad0de05","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"ce3be64b-a968-59e2-b206-5a055de98330","slug":"prescribing-information","fullItemName":"Prescribing information"},"subChapters":[{"id":"b8cb4ab4-ee29-5947-9037-358622456129","slug":"availablity-choice","fullItemName":"Availablity and choice","depth":3,"htmlHeader":"<!-- begin field f02def80-eb70-4185-9609-fa0c3499d0d2 --><h3>Availability and choice</h3><!-- end field f02def80-eb70-4185-9609-fa0c3499d0d2 -->","summary":"","htmlStringContent":"<!-- begin item 9b05d315-0d6b-4764-acf7-0e2bc792bdce --><!-- begin field 7106abb4-3929-453f-a5de-33aa411f72ba --><ul><li>Several coal tar preparations are available in the UK including ointments, shampoos, and bath additives. Various preparations are combined with other topical treatments for the management of psoriasis (for example salicylic acid).</li><li>The choice of coal tar preparation should take into consideration product availability, the skin site, previous response to treatment, and the person's preference.<ul><li>Newer, branded products are preferred because older, non-branded products contain crude coal tar (coal tar BP) which is smellier and usually messier to use.</li></ul></li><li>Preparations suitable for treating scalp psoriasis include:<ul><li>Alphosyl 2 in 1<sup>®</sup> shampoo (alcoholic coal tar extract 5%).</li><li>Capasal<sup>®</sup> shampoo (coal tar 1%, coconut oil 1%, salicylic acid 0.5%).</li><li>Polytar liquid<sup>®</sup> shampoo (coal tar 1%).</li><li>Psoriderm<sup>®</sup> — scalp lotion is also a shampoo (coal tar 2.5%, lecithin 0.3%).</li><li>T/Gel<sup>®</sup>shampoo (coal tar extract 2%).</li><li>Exorex<sup>®</sup> lotion (coal tar 1%).</li><li>Sebco<sup>®</sup> scalp ointment (coal tar solution 12%, salicylic acid 2%, sulphur 2%).</li><li>Note: do not use coal tar shampoos such as Polytar<sup>®</sup>, Alphosyl 2:1<sup>®</sup>, or Capasal<sup>®</sup> alone for treating severe scalp psoriasis.</li></ul></li><li>Preparations suitable for treating psoriasis on the trunk and limbs include:<ul><li>Exorex<sup>®</sup> lotion (coal tar 1%).</li><li>Psoriderm<sup>®</sup> cream (coal tar 6<strong>%</strong>).</li></ul></li><li>Bath additives include:<ul><li>Polytar Emollient<sup>®</sup> bath additive (coal tar solution 2.5%, peanut oil, extract of coal tar 7.5%, tar 7.5%, cade oil 7.5%, liquid paraffin 35%).</li><li>Psoriderm<sup>®</sup> bath emulsion (coal tar 40%).</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/psoriasis/references/\">BNF 73, 2017</a>]</p><!-- end field 7106abb4-3929-453f-a5de-33aa411f72ba --><!-- end item 9b05d315-0d6b-4764-acf7-0e2bc792bdce -->","subChapters":[]},{"id":"69c20015-99be-5d7c-abd7-47f49f2d38a5","slug":"contraindications-cautions","fullItemName":"Contraindications and cautions","depth":3,"htmlHeader":"<!-- begin field 209ba7b7-394e-4a98-a5bb-905170bc8059 --><h3>Contraindications and cautions</h3><!-- end field 209ba7b7-394e-4a98-a5bb-905170bc8059 -->","summary":"","htmlStringContent":"<!-- begin item 222b4953-7efc-4717-857f-66ab028eb0e0 --><!-- begin field c30065c7-4891-493d-a3e6-e5e69b21e78f --><p><strong>Do not prescribe coal tar preparations to people:</strong></p><ul><li>With broken or inflamed skin.</li><li>With skin infection.</li><li>With sore, acute, or pustular psoriasis.</li><li>With genital or rectal psoriasis.</li><li>Who are pregnant — avoid the use of coal tar preparations in the first trimester of pregnancy.</li></ul><p><strong>Prescribe coal tar with caution to people:</strong></p><ul><li>Applying to the face (particularly around the eyes) or skin flexures.</li><li>Who are pregnant — use coal tar preparations with caution in the second and third trimesters of pregnancy if the expected benefit to the mother outweighs the potential risk to the infant.</li><li>Who are breastfeeding — use coal tar preparations with caution if the expected benefit to the mother outweighs the potential risk to the infant, and ensure the infant does not come into direct contact with treated skin to avoid accidental ingestion by the infant.</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/psoriasis/references/\">BNF 73, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/psoriasis/references/\">ABPI, 2015</a>] </p><!-- end field c30065c7-4891-493d-a3e6-e5e69b21e78f --><!-- end item 222b4953-7efc-4717-857f-66ab028eb0e0 -->","subChapters":[]},{"id":"d0486402-11e0-557e-a21a-9668cdad2bdd","slug":"adverse-effects","fullItemName":"Adverse effects","depth":3,"htmlHeader":"<!-- begin field f4a049de-3b7a-446a-a60f-5cd56a817242 --><h3>What adverse effects are associated with coal tar products?</h3><!-- end field f4a049de-3b7a-446a-a60f-5cd56a817242 -->","summary":"","htmlStringContent":"<!-- begin item 2181e723-ed76-4874-aa69-0cc7c63d17db --><!-- begin field 460bf035-0d20-47a2-876e-662e8ff11c4e --><ul><li>Coal tar preparations can cause adverse effects such as:<ul><li>Photosensitivity — advise the person to minimize exposure to sunlight and avoid sunlamps after treatment (unless this is specifically indicated).</li><li>Skin irritation, acneiform eruptions, folliculitis.</li><li>Staining of skin, hair, or fabric.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/psoriasis/references/\">BNF 73, 2017</a>]</p><!-- end field 460bf035-0d20-47a2-876e-662e8ff11c4e --><!-- end item 2181e723-ed76-4874-aa69-0cc7c63d17db -->","subChapters":[]},{"id":"c6caa031-3dee-5a13-a8c2-4cbbb7171468","slug":"application","fullItemName":"Application","depth":3,"htmlHeader":"<!-- begin field 401879d2-1c86-4840-b2e0-80946f0c099f --><h3>Application</h3><!-- end field 401879d2-1c86-4840-b2e0-80946f0c099f -->","summary":"","htmlStringContent":"<!-- begin item 247962e5-19b2-4d2b-9e5f-508d077919bc --><!-- begin field c92764a0-6351-47be-80ab-c64373d03e58 --><p><strong>The method of application depends on the coal tar product:</strong></p><ul><li>Creams, ointments, and pastes — these are generally applied by wiping onto the entire plaque once or twice a day (away from flexural areas).</li><li>Scalp preparations — these are applied once a week, left on for one hour and then shampooed off. For severe psoriasis, this can be repeated daily for the first 3–7 days; thereafter, they are usually applied once a week (and shampooed off after one hour).</li><li>Bath additives — directions for use vary but, in general, a measured amount is added to the bath and the person soaks in the bath for 5–20 minutes.</li><li>Shampoos — directions for use vary. Some preparations may be used daily, and others are restricted to use once or twice a week.</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/psoriasis/references/\">BNF 73, 2017</a>] </p><!-- end field c92764a0-6351-47be-80ab-c64373d03e58 --><!-- end item 247962e5-19b2-4d2b-9e5f-508d077919bc -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}